253 related articles for article (PubMed ID: 902377)
41. The relationship between plasma dobutamine concentrations and cardiovascular responses in cardiac failure.
Leier CV; Unverferth DV; Kates RE
Am J Med; 1979 Feb; 66(2):238-42. PubMed ID: 425967
[TBL] [Abstract][Full Text] [Related]
42. Comparative haemodynamic effects of dobutamine and isoproterenol in man.
Rigaud M; Boschat J; Rocha P; Ferreira A; Bardet J; Bourdarias JP
Intensive Care Med; 1977 Aug; 3(2):57-62. PubMed ID: 893774
[TBL] [Abstract][Full Text] [Related]
43. Right ventricular-vascular interaction in congestive heart failure. Importance of low-frequency impedance.
Kussmaul WG; Altschuler JA; Matthai WH; Laskey WK
Circulation; 1993 Sep; 88(3):1010-5. PubMed ID: 8353862
[TBL] [Abstract][Full Text] [Related]
44. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure.
Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN
Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184
[TBL] [Abstract][Full Text] [Related]
45. [Hemodynamic shifts in patients with congestive heart failure during treatment with sodium nitroprusside].
Tatishvili NI; Chkhaidze ZK; Kurashvili RB; Mamatsashvili MD; Narsiia NN
Kardiologiia; 1983 Jul; 23(7):28-31. PubMed ID: 6620808
[TBL] [Abstract][Full Text] [Related]
46. Combined hemodynamic effects of dobutamine and IV nitroglycerin in congestive heart failure.
Gagnon RM; Fortin L; Boucher R; Gilbert S; Morrisette M; Present S; Lemire J; David A
Chest; 1980 Nov; 78(5):694-8. PubMed ID: 6775881
[TBL] [Abstract][Full Text] [Related]
47. Comparison of hemodynamic responses to nifedipine and nitroprusside in severe chronic congestive heart failure.
Elkayam U; Weber L; Torkan B; McKay CR; Rahimtoola SH
Am J Cardiol; 1984 May; 53(9):1321-5. PubMed ID: 6711434
[TBL] [Abstract][Full Text] [Related]
48. Haemodynamic effects of dobutamine in patients with coronary artery disease.
Magnani B; Ambrosioni E; Branzi A; Picchio F; Capitanucci P
J Int Med Res; 1977; 5(1):10-7. PubMed ID: 838109
[TBL] [Abstract][Full Text] [Related]
49. Afterload reduction therapy with nitroprusside in severe aortic regurgitation: improved cardiac performance and reduced regurgitant volume.
Miller RR; Vismara LA; DeMaria AN; Salel AF; Mason DT
Am J Cardiol; 1976 Nov; 38(5):564-7. PubMed ID: 983953
[TBL] [Abstract][Full Text] [Related]
50. Comparative responses to dobutamine and nitroprusside in patients with chronic low output cardiac failure.
Berkowitz C; McKeever L; Croke RP; Jacobs WR; Loeb HS; Gunnar RM
Circulation; 1977 Dec; 56(6):918-24. PubMed ID: 923060
[TBL] [Abstract][Full Text] [Related]
51. Comparative hemodynamic effects of intravenous dobutamine and dibutyryl cyclic AMP, a new inotropic agent, in severe congestive heart failure.
Miyagi Y; Sasayama S; Nakajima H; Fujita M; Asanoi H
J Cardiovasc Pharmacol; 1990 Jan; 15(1):138-43. PubMed ID: 1688971
[TBL] [Abstract][Full Text] [Related]
52. Hemodynamic effects of dobutamine in patients below and over 65 years, with left heart failure secondary to an acute myocardial infarction.
Renard M; Bernard R; Melot C; Jacobs P; Englert M
Gerontology; 1984; 30(6):408-13. PubMed ID: 6519441
[TBL] [Abstract][Full Text] [Related]
53. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
54. Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure.
Petein M; Levine TB; Cohn JN
J Am Coll Cardiol; 1984 Aug; 4(2):364-71. PubMed ID: 6736478
[TBL] [Abstract][Full Text] [Related]
55. [Effects of a sodium nitroprusside-dobutamine combination in left cardiac failure].
Moore N; Champoud O; Berland J; Cribier A; Letac B
Therapie; 1985; 40(2):99-103. PubMed ID: 4002197
[No Abstract] [Full Text] [Related]
56. Assessment of vasodilator therapy in patients with severe congestive heart failure: limitations of measurements of left ventricular ejection fraction and volumes.
Firth BG; Dehmer GJ; Markham RV; Willerson JT; Hillis LD
Am J Cardiol; 1982 Nov; 50(5):954-9. PubMed ID: 6291370
[TBL] [Abstract][Full Text] [Related]
57. Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine.
Jaski BE; Peters C
Am J Cardiol; 1988 Aug; 62(5):63C-67C. PubMed ID: 3407597
[TBL] [Abstract][Full Text] [Related]
58. Comparison of hemodynamic actions of pirbuterol and dobutamine on cardiac function in severe congestive heart failure.
Awan NA; Needham KE; Evenson MK; Mason DT
Am J Cardiol; 1981 Mar; 47(3):665-9. PubMed ID: 7468500
[No Abstract] [Full Text] [Related]
59. Hemodynamic correlates of left ventricular versus right ventricular radionuclide volumetric responses to vasodilator therapy in congestive heart failure secondary to ischemic or dilated cardiomyopathy.
Konstam MA; Weiland DS; Conlon TP; Martin TT; Cohen SR; Eichhorn EJ; Isner JM; Zile MR; Salem DN
Am J Cardiol; 1987 May; 59(12):1131-7. PubMed ID: 3578055
[TBL] [Abstract][Full Text] [Related]
60. Acute hemodynamic effects of piroximone (MDL 19,205) in patients with moderate congestive heart failure: comparison with sodium nitroprusside.
Arbogast R; Brandt CM; Fincker JL; Schechter PJ
J Cardiovasc Pharmacol; 1986; 8(1):82-9. PubMed ID: 2419699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
